Dr. Doyle's otology/neurotology practice concentrates on surgical treatment of ear and balance disorders including hearing loss, ear infections, balance disturbances, vertigo syndromes, and other conditions that produce hearing and balance problems.Research Focus
Dr. Doyle has two research areas: Identification of hearing loss in infants The effects of ototoxic medications on the inner ear
General Otolaryngology Clinic
2521 Stockton Blvd., Suite 5200
Sacramento, CA 95817
Ph.D., UC Santa Barbara, Santa Barbara, 1984
B.A., University of Michigan, Ann Arbor, Michigan, 1976
American Academy of Otolaryngology-Head and Neck Surgery
American Auditory Society
American Neurotology Society
American Otological Society
Association for Research in Otolaryngology
Sacramento Society of Otolaryngology
Society of University Otolaryngologists
Select Honors and Awards:
Elected Board Member, American Auditory Society, 2002
Coordinator, Otology/Neurotology Section, National Resident Curriculum Committee, American Academy of Otolaryngology-Head and Neck Surgery Foundation, 2001
Phi Bet Kappa, 1976
Select Recent Publications:
Nie L, Feng W, Diaz R, Gratton MA, Doyule KJ, Yamoah EN. Functional consequenses of inhibition of polyamine synthesis by DFMO: Cellular mechanisms for DFMO-mediated ototoxicity. Journal of Biological Chemistry 2005
Rosenfeld RM, Culpepper L, Doyle KJ, Grundfast KM, Hoberman A, Kenna MA, Lieberthal AS, Mahoney M, Wahl RA, Woods CR, Yawn B. Clinical Practice guideline: Otitis media with effusion. Otolaryngolgy Head Neck Surg 2004: 130(5Suppl):S95-S118.
Smith M, Doyle KJ, Tinling SP. DFMO-induced hearing loss across wide frequency range. Laryngoscope 2004:114:1113-17.
Grandis J, Zanboni G, Wagener M, Miller , Doyle KJ, NcJubbib S. The gender gap in surgical subspecialty: analysis of career and lifestyle factors. Arch Otolaryngol Head Neck Surg 2004; 130:695-702
Doyle KJ, et all. Intratympanic steroid treatment: A review. Otology and Neurotology 2004;25:1034-9.
Doyle KJ, Kong YY, Strobel K, Dallaire P, Ray RM. Neonatal middle ear effusion predicts chronic otitis media with effusion. Otology & Neurotology 2004: 25:318-22.
Doyle KJ, Meyskens FL, McLaren C, Shanks J, Galus C. Effects of DFMO chemoprevention on audiometry thresholds and otoacoustic emissions. Arch Otolaryngol Head Neck Surg 2001; 127:553-8.
Doyle KJ. Delayed, reversible hearing loss caused by difluoromethylornithine (DFMO). Laryngoscope 2001;111:781-5.
Buckmiller LM, Brodie HA, Doyle KJ, Nemzek W. Choristoma of the middle ear: A component of a new syndrome? Otology & Neurotology 2001;22:363-8.